Company Filing History:
3 out of 443 
3 out of 1,373 
1 out of 15,475 
Years Active: 2023-2025
Title: Kurt Cox: Innovator in RNA-guided Nuclease Technology
Introduction
Kurt Cox is a prominent inventor based in Cambridge, MA (US), known for his significant contributions to the field of molecular biology. He holds a total of 4 patents, focusing on innovative methods and compositions that enhance our understanding and manipulation of genetic material.
Latest Patents
Cox's latest patents include groundbreaking work on inhibitors of RNA-guided nuclease activity. These compositions and methods are designed to inhibit the function of RNA-guided endonucleases, providing valuable tools for researchers. His inventions also encompass nucleic acid modifiers, which relate to site-specific delivery of nucleic acid modifiers. This includes novel DNA-binding proteins and effectors that can be programmed for precise DNA modifications. Additionally, he has developed synthetic all-in-one genome editor (SAGE) systems that comprise designer DNA sequence readers and small molecules to facilitate various genetic modifications.
Career Highlights
Throughout his career, Kurt Cox has worked with esteemed organizations such as the Broad Institute, Inc. and Brigham and Women's Hospital, Inc. His work in these institutions has allowed him to collaborate with leading scientists and contribute to cutting-edge research in genetics and molecular biology.
Collaborations
Cox has collaborated with notable colleagues, including Amit Choudhary and Hari Subramanian. These partnerships have further enriched his research and innovation in the field.
Conclusion
Kurt Cox's contributions to RNA-guided nuclease technology and nucleic acid modifiers have positioned him as a key figure in molecular biology. His innovative patents and collaborations continue to influence the landscape of genetic research and applications.